TransMedics Income Statement 2018-2025 | TMDX

Revenue

$241.623

$93.459

$30.262

$25.639

$23.604

$13.017

Cost Of Goods Sold

$87.53

$28.187

$9.103

$9.004

$9.741

$7.283

Gross Profit

$154.093

$65.272

$21.159

$16.635

$13.863

$5.734

Research And Development Expenses

$63.267

$26.812

$22.304

$18.831

$19.87

$13.656

SG&A Expenses

$119.553

$69.897

$38.283

$24.188

$23.596

$12.315

Other Operating Income Or Expenses

Operating Expenses

$182.82

$96.709

$60.587

$43.019

$43.466

$25.971

Operating Income

$-28.727

$-31.437

$-39.428

$-26.384

$-29.603

$-20.237

Total Non-Operating Income/Expense

$2.056

$-4.728

$-4.751

$-2.332

$-3.904

$-3.478

Pre-Tax Income

$-26.671

$-36.165

$-44.179

$-28.716

$-33.507

$-23.715

Income Taxes

$-1.643

$0.066

$0.036

$0.032

$0.04

$0.041

Income After Taxes

$-25.028

$-36.231

$-44.215

$-28.748

$-33.547

$-23.756

Other Income

Income From Continuous Operations

$-25.028

$-36.231

$-44.215

$-28.748

$-33.547

$-23.756

Income From Discontinued Operations

Net Income

$-25.028

$-36.231

$-44.215

$-28.748

$-33.547

$-23.756

EBITDA

$-20.55

$-27.959

$-37.611

$-24.807

$-28.381

$-19.468

EBIT

$-28.727

$-31.437

$-39.428

$-26.384

$-29.603

$-20.237

Basic Shares Outstanding

Shares Outstanding

Basic EPS

$-0.77

$-1.23

$-1.60

$-1.16

$-2.36

$-17.48

EPS - Earnings Per Share

$-0.77

$-1.23

$-1.60

$-1.16

$-2.36

$-17.48